Molecular Share Price
NASDAQ: MOLN | Others$0.00
+0.00 (0.00%) Molecular Stock Performance
Molecular Share Price Chart
$0.00$0.00
L
H
Molecular Annual Profit & Loss
All figures in USD
Molecular Balance Sheet
All figures in USD Million
Molecular Cash Flow
Annually
All figures in USD Million
About Molecular
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Molecular Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.07 | $3.46 | -4.68% |
Oct 2026 | $3.63 | $3.63 | -5.47% |
Sep 2026 | $3.84 | $3.84 | -6.57% |
Aug 2026 | $4.11 | $4.11 | +2.75% |
Jul 2026 | $4.00 | $4.00 | +3.90% |
Jun 2026 | $3.88 | $3.85 | -3.27% |
May 2026 | $4.22 | $3.98 | -2.33% |
Apr 2026 | $4.08 | $4.08 | -2.40% |
Mar 2026 | $4.88 | $4.17 | -12.66% |
Feb 2026 | $4.45 | $4.78 | +16.59% |
Jan 2026 | $4.12 | $4.10 | -3.98% |
Dec 2025 | $4.02 | $4.27 | +1.91% |